WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Dmitry Samarsky, Ph.D., Vice President of Technology Development, will be presenting at the Discovery on Target scientific conference in Boston, MA tomorrow, November 4, 2009. The presentation will not be webcasted.
